Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05979220
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-05-19
Brief Title:
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy
Sponsor:
Shuangyue Liu
Organization:
West China Hospital
Organization Data
Organization:
West China Hospital
Class:
OTHER
Study ID:
OBU-SC-BC-II-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shuangyue Liu
Lead Sponsor Class:
OTHER
Responsible Party:
Shuangyue Liu
Responsible Party Title:
Clinical Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
West China Hospital
Old Name:
None
Old Organization:
None